Leukaemia breakthrough: Major discovery sees huge breakthrough in cancer treatment- NASA News
If you’re able, and if you like our content and approach, please support we. Our work wouldn’t be possible without your help.
A trial of the new drug asciminib found that the drug is “well tolerated” by patients whilst remaining effective in battling the disease. Typically drugs for chronic myeloid leukaemia bring with them risks of a litany of side-effects including vomiting, diarrhoea and muscle pain adding further suffering to those already facing the cancer. The new drug has been hailed as a “breakthrough” as it does not inadvertently kill healthy cells at the same time, the cause of the side effects. Results of the 150 person trial of sufferers found the drug was not toxic and appeared to work effectively inside the patients. The new drug works by slowing down the cancer through shutting down specific cancer causing enzymes called Kinases — it is part of a class of drugs known as tyrosine kinase inhibitors (TKI).Study co-author Professor Tim Hughes, of the South Australian Health and Medical Research Institute, praised the potential of the drug over its previous counterparts like Imatinib. He said: “[Imatinib] changed CML from a death sentence to a disease that in many patients could be managed until they lived to a ripe old age.“But while imatinib and subsequent TKIs have been very effective at improving survival, they frequently cause serious side-effects.”Professor Hughes claimed…